HEALTHCARE CHINA 2017, the Next Investment Opportunities for Healthcare after TPP Conference
January 8 - 11, 2017, TPP Healthcare Conference was concurrently held with J.P. Morgan Healthcare 2017 at Parc 55 near Union Square in San Francisco, with 150 audience members,30 panelists, 300 checked in from China and nearly 6.5k impressions on TPP’s Twitter account.
TPP Healthcare topics spanned the entire healthcare and investment industry including, among others:‘An Overview of the Chinese Pharmaceutical Market’, ‘Why Chinese Capital and Its Dramatic Increased Activities into US and EU’, ‘Access the China Healthcare Market and Investment Capital’, and ‘Optimal Deal Structures with Chinese Investors and Strategic Partners’.
As one of the co-organisers of TPP Healthcare, we, Reed Sinopharm Exhibitions, actively participated in the event and conversed with various American healthcare and investment companies. We also gave a presentation about the upcoming conference in May: HEALTHCARE CHINA 2017.
China’s healthcare market needs further innovation and the government continues to provide its support. Morgan Stanley recently reported that the Chinese Ministry of Health has committed$590 billion in investment towards national healthcare within the past ten years alone. That is no small number. The next phase - new drug innovations, medical devices, medical services, and internet & smarter healthcare, are all predicted to be the most popular investment fields in the coming years.
HEALTHCARE CHINA 2017 (May 12-14) serves as a summit forging the bridge between investment and the healthcare industry, and over1,000 delegates from the business and investment sectors will attend. Senior executives from around the healthcare industry, investment institutions, insurance/consultancy companies and research institutions all took part in HEALTHCARE CHINA 2016, where they found abundant investment opportunities in healthcare.
In HEALTHCARE CHINA 2017, experts from a variety of fields will be invited to explain the newly launched policies and explore more investment opportunities in the healthcare industry.
Furthermore, to explore and help developing companies, HEALTHCARE CHINA 2017 will be providing opportunities for innovative enterprises to introduce, among others, their profile, products, services, collaborative projects and financing needs.
HEALTHCARE CHINA 2017 Highlights:
Links together over 7,000 healthcare companies and investors from around the world
Focuses on the 4 most popular investment fields in the healthcare industry: BIO, Medical Devices & IVD, Medical Services, Digital Health
Features founders/CEOs of the top 80 most innovative companies
Profiles over 300 CEOs and more than 300 high-profile investment agency founders/partners of the industry
Make this year count. Be part of HEALTHCARE CHINA 2017, and explore your next business opportunity!